Etico Chemicals India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-11-2024
- Paid Up Capital ₹ 1.50 M
as on 06-11-2024
- Company Age 3 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 Cr
as on 06-11-2024
- Revenue 705.46%
(FY 2023)
- Profit -4468.98%
(FY 2023)
- Ebitda -4240.15%
(FY 2023)
- Net Worth -534.27%
(FY 2023)
- Total Assets 1074.55%
(FY 2023)
About Etico Chemicals India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹10.00 Cr.
Phani Devarapalli, Ashok Aluri, and Mohd Shaik serve as directors at the Company.
- CIN/LLPIN
U24290TG2021PTC157795
- Company No.
157795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Etico Chemicals India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Phani Devarapalli  | Director | 09-Dec-2021 | Current |
| Ashok Aluri | Director | 09-Dec-2021 | Current |
| Mohd Shaik | Director | 17-Sep-2022 | Current |
Financial Performance of Etico Chemicals India.
Etico Chemicals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 705.46% increase. The company also saw a substantial fall in profitability, with a 4468.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 534.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Etico Chemicals India?
Unlock access to Etico Chemicals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Trioka Projects Private LimitedActive 10 years 2 months
Phani Devarapalli and Ashok Aluri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Nov 2022 | ₹10.00 Cr | Open |
How Many Employees Work at Etico Chemicals India?
Unlock and access historical data on people associated with Etico Chemicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Etico Chemicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Etico Chemicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
